Page last updated: 2024-10-26

diclofenac and Injury, Myocardial Reperfusion

diclofenac has been researched along with Injury, Myocardial Reperfusion in 2 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rossoni, G1
Sparatore, A1
Tazzari, V1
Manfredi, B1
Del Soldato, P1
Berti, F1
Bouchard, JF1
Lamontagne, D1

Other Studies

2 other studies available for diclofenac and Injury, Myocardial Reperfusion

ArticleYear
The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart.
    British journal of pharmacology, 2008, Volume: 153, Issue:1

    Topics: Animals; Creatine Kinase; Diclofenac; Epoprostenol; Glutathione; Glyburide; Heart; Hydrogen Sulfide;

2008
Mechanisms of protection afforded by cyclooxygenase inhibitors to endothelial function against ischemic injury in rat isolated hearts.
    Journal of cardiovascular pharmacology, 1999, Volume: 34, Issue:5

    Topics: Animals; Arachidonic Acid; Cardiotonic Agents; Coronary Circulation; Coronary Vessels; Cyclooxygenas

1999